VAS.DEVAS.DEXETRA
Loading
EBITDA Over TimeContracting
Percentile Rank21
3Y CAGR-14.1%
5Y CAGR+12.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-14.1%/yr
vs +3.1%/yr prior
5Y CAGR
+12.0%/yr
Recent deceleration
Acceleration
-17.1pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.40B-19.5%
2024$1.74B-28.7%
2023$2.44B+10.6%
2022$2.20B+105.3%
2021$1.07B+35.0%
2020$795.30M-49.8%
2019$1.58B-18.9%
2018$1.95B+24.6%
2017$1.57B-2.8%
2016$1.61B-